Baba: You just don't get it, do you....neither do I. 

What's not to get Baba, aside from the very engaged and optimistic crew here on this forum (of which I'm a certified card carrying member), it seems the world continues to see us in a much more objective way.  That is, POET's a fairly high risk micro-cap tech start-up with no sales revenue expected until well into 2021, and no profits until.....well, we don't know when.

I think we can all agree there's absolutely loads of potential with this company, but it's also very clear there's still very little appreciation or understanding of this from the market as a whole, or perhaps it's a perception the potential is still far enough away that they prefer to park their money elsewhere in the interim.

The fact that we saw no lasting response to the Sanan LOI announcement, coupled with 2020 revenue limited to whatever NRE deals that may come our way, tells me we're going to need something significantly better than the Sanan announcement to get the warrants in play.  I suppose there's a chance word finally starts percolating through industry and those in the know become convinced and start buying in, but seems to me that would be a slower process.

As for the "wall" having to do with our current SP situation, to me it's a rationalization to explain a stall in SP.  IMO, if there's enough demand on the buy side, the wall disappears.  A recent example, a small Canadian biotech (IMV) toiling away on cancer vaccine research, making little headway from a valuation standpoint, recently made a series of announcements related to Covid vaccine development, a single trading day (on Nas) they churned 60M shares, essentially their entire float.  Sure, an extreme example, but the point is that buying pressure has a tendency to solve all sorts of problems.